|
Subject
|
Sex
|
Time between MRI scans (months)
|
Pain change score
|
Baseline SIS
|
Follow-up SIS
|
Baseline Erosion
|
Follow-up Erosion
|
NSAIDs
|
cDMARD
|
TNFi exposure (days)
|
|---|
|
1
|
M
|
8.5
|
–
|
34.7
|
7
|
11
|
4.3
|
None
|
None
|
0
|
|
2
|
M
|
33.8
|
−4
|
14.3
|
0
|
5.3
|
5.7
|
Yes
|
MTX
|
0
|
|
3
|
M
|
22.1
|
–
|
3
|
0
|
0
|
0
|
Yes
|
SSZ
|
0
|
|
4
|
M
|
5.8
|
–
|
13.3
|
4
|
5
|
9
|
Yes
|
None
|
0
|
|
5
|
M
|
36.0
|
–
|
30.7
|
16
|
0
|
0
|
Yes
|
None
|
0
|
|
6
|
F
|
35.7
|
–
|
24.7
|
4.5
|
0
|
4.7
|
Yes
|
SSZ
|
0
|
|
7
|
M
|
7.5
|
−1
|
10.3
|
0
|
0
|
0
|
Yes
|
None
|
0
|
|
8
|
F
|
2.9
|
−1
|
28.5
|
0
|
10
|
13
|
Yes
|
MTX
|
67
|
- Legend. M = Male, F=Female, NSAIDs = nonsteroidal anti-inflammatory drugs, csDMARD = conventional disease modifying anti-rheumatic drug; MTX = methotrexate, SSZ = sulfasalazine
